XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenues        
Revenues $ 2,403 $ 2,167 $ 4,556 $ 4,111
Expenses        
Selling, general and administrative 832 711 1,626 1,436
Research and development 156 156 307 299
Amortization of intangible assets 270 269 544 542
Asset impairments 5 37 6 50
Restructuring, integration and separation costs 12 16 24 26
Other expense (income), net 20 (83) 20 (60)
Total expenses 2,014 1,755 3,886 3,524
Operating income 389 412 670 587
Interest income 8 7 17 13
Interest expense (350) (319) (705) (626)
Gain on extinguishment of debt 12 0 23 0
Foreign exchange and other (11) (21) (26) (31)
Income (loss) before income taxes 48 79 (21) (57)
Provision for income taxes (49) (52) (57) (125)
Net (loss) income (1) 27 (78) (182)
Net loss (income) attributable to noncontrolling interest 11 (1) 24 7
Net income (loss) attributable to Bausch Health Companies Inc. $ 10 $ 26 $ (54) $ (175)
Earnings (loss) per share attributable to Bausch Health Companies Inc.        
Basic (in usd per share) $ 0.03 $ 0.07 $ (0.15) $ (0.48)
Diluted (in usd per share) $ 0.03 $ 0.07 $ (0.15) $ (0.48)
Weighted-average common shares        
Basic (in shares) 367.9 364.8 367.4 364.1
Diluted (in shares) 370.2 367.1 367.4 364.1
Product sales        
Revenues        
Revenues $ 2,379 $ 2,146 $ 4,508 $ 4,068
Expenses        
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 708 640 1,336 1,212
Other revenues        
Revenues        
Revenues 24 21 48 43
Expenses        
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues $ 11 $ 9 $ 23 $ 19